Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today authorized 23andMe's genetic health risk report for three BRCA1 and BRCA2 mutations most commonly found in people of Ashkenazi Jewish descent.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
27
Sponsored by
LGC SeraCare Life Sciences

This webinar brings together an expert panel of stakeholders in cancer diagnostics and clinical care who will discuss the promise and challenges of liquid biopsy technologies in cancer diagnosis, monitoring, and patient care management.